Beware of These "Safe" Dow Stocks

Watch stocks you care about

The single, easiest way to keep track of all the stocks that matter...

Your own personalized stock watchlist!

It's a 100% FREE Motley Fool service...

Click Here Now

Lately, many investors have sought protection from a potential downturn by turning to low-volatility stocks, which they perceive as somehow being safer than higher-volatility stocks. Yet even among the 30 blue-chip stocks in the Dow Jones Industrials (DJINDICES: ^DJI  ) , you'll find that low volatility is no guarantee of protection during downdrafts in the overall market.

Why low volatility seems appealing
Over the past year or so, low-volatility stocks have gained notoriety as being better long-term performers than their higher-volatility counterparts. Several studies have established that when you look at long-term returns, low-volatility stocks often produce better results than high-volatility stocks, even though the greater risk involved with high-volatility stocks should theoretically reward investors with higher returns.

But often, phenomena such as low-volatility stock outperformance prove vulnerable once investors grab onto strategies that seek to exploit historical share-price behavior. Recently, we've seen exactly that vulnerability within the Dow.

A short-term reversal of fortune for low-vol stocks
From May 28 to June 5, the Dow dropped almost 450 points, or about 3%. Based on past history, what investors would have expected was for low-volatility stocks to post more modest declines while high-volatility stocks dropped more sharply.

Yet the actual returns of many of the Dow's components point to the contrary. Pfizer (NYSE: PFE  ) and Procter & Gamble (NYSE: PG  ) both lost more than 5% despite having betas that would suggest only half the volatility of the overall market. Verizon (NYSE: VZ  ) also weighed in with an almost 5% pullback even with a beta of 0.8.

Has the low-vol strategy stopped working?
The key to understanding these results rests on a few observations. First and foremost, judging a long-term strategy over a period of a single week is completely unreasonable. Even a fully functional strategy can produce aberrant results in the short run.

But the other thing to note is that as these low-volatility stocks have gotten popular, their prices have risen. In particular, P&G has the distinction of being in the defensive consumer-staples industry, which has been a place where many investors have turned looking for safety. Similarly, Pfizer and Verizon are both high-dividend stocks, which have been in high demand given the low interest rate environment. An upturn in bond yields has weighed on many dividend stocks, even those with relatively low volatilities.

Don't jump to conclusions
The key takeaway from the current behavior of low-volatility Dow stocks is that even a completely valid strategy can produce undesirable results when it gets too popular. Long-term investors should actually hope that more short-term-focused investors lose faith in the low-vol strategy, as that would make the strategy more likely to work in the future.

If you're looking for some long-term investing ideas, you're invited to check out The Motley Fool's brand-new special report, "The 3 Dow Stocks Dividend Investors Need." It's absolutely free, so simply click here now and get your copy today.

Read/Post Comments (1) | Recommend This Article (9)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On June 10, 2013, at 10:26 AM, EllenBrandtPhD wrote:


    Whatever you think about PFE later in the summer, it is now only 8 trading days until the Zoetis conversion.

    If successful - and the PFE contingent among Da Boyz will try hard to make it so - it both brings in nice cash to PFE and lowers its share count - so a double reverse whammy.

    Analysts will have two choices: raising ratings and Targets to reflect it before the fact or letting PFE have a nice surprise "beat" at its next earnings report.

    In sum, it could be very dangerous to be Short PFE right now.

    (And that's why the "underperformance" last week. MMs took her down to give Shorts among their peers a chance to cover, while Hedgies who had dumped earlier were given a chance to come in again. OK by me.)

Add your comment.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2478985, ~/Articles/ArticleHandler.aspx, 9/30/2016 8:16:54 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,308.15 164.70 0.91%
S&P 500 2,168.27 17.14 0.80%
NASD 5,312.00 42.85 0.81%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/30/2016 5:01 PM
^DJI $18308.15 Up +164.70 +0.91%
PFE $33.87 Up +0.55 +1.65%
Pfizer CAPS Rating: ****
PG $89.75 Up +1.52 +1.72%
Procter and Gamble CAPS Rating: ****
VZ $51.98 Down -0.14 -0.27%
Verizon Communicat… CAPS Rating: ****